- Home
- OCC vs LVTX Comparison
OCC vs LVTX Comparison
Compare OCC & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- LVTX
- Stock Information
- Founded
- OCC 1983
- LVTX 2016
- Country
- OCC United States
- LVTX Netherlands
- Employees
- OCC N/A
- LVTX N/A
- Industry
- OCC Telecommunications Equipment
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- OCC Industrials
- LVTX Health Care
- Exchange
- OCC Nasdaq
- LVTX Nasdaq
- Market Cap
- OCC 40.9M
- LVTX 33.9M
- IPO Year
- OCC 1996
- LVTX 2021
- Fundamental
- Price
- OCC $5.32
- LVTX $1.52
- Analyst Decision
- OCC
- LVTX Hold
- Analyst Count
- OCC 0
- LVTX 4
- Target Price
- OCC N/A
- LVTX $1.58
- AVG Volume (30 Days)
- OCC 74.1K
- LVTX 168.1K
- Earning Date
- OCC 09-10-2025
- LVTX 08-13-2025
- Dividend Yield
- OCC N/A
- LVTX N/A
- EPS Growth
- OCC N/A
- LVTX N/A
- EPS
- OCC N/A
- LVTX N/A
- Revenue
- OCC $68,999,601.00
- LVTX $4,990,000.00
- Revenue This Year
- OCC N/A
- LVTX N/A
- Revenue Next Year
- OCC N/A
- LVTX N/A
- P/E Ratio
- OCC N/A
- LVTX N/A
- Revenue Growth
- OCC 5.77
- LVTX N/A
- 52 Week Low
- OCC $2.02
- LVTX $0.85
- 52 Week High
- OCC $7.00
- LVTX $2.09
- Technical
- Relative Strength Index (RSI)
- OCC 53.31
- LVTX 57.51
- Support Level
- OCC $5.01
- LVTX $1.51
- Resistance Level
- OCC $6.06
- LVTX $1.69
- Average True Range (ATR)
- OCC 0.54
- LVTX 0.09
- MACD
- OCC -0.09
- LVTX -0.00
- Stochastic Oscillator
- OCC 57.34
- LVTX 50.00
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.